Home/Filings/4/0001104659-23-069501
4//SEC Filing

Morris Richard Steven 4

Accession 0001104659-23-069501

CIK 0001485003other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 6:18 PM ET

Size

5.7 KB

Accession

0001104659-23-069501

Insider Transaction Report

Form 4
Period: 2023-06-06
Morris Richard Steven
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-06+238,000238,000 total
    Exercise: $7.25Exp: 2033-06-06Common Stock (238,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest over four years, with 25% of the shares vesting on June 6, 2024 and the remaining shares vesting over the next three years thereafter in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.

Issuer

Carisma Therapeutics Inc.

CIK 0001485003

Entity typeother

Related Parties

1
  • filerCIK 0001432303

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 6:18 PM ET
Size
5.7 KB